BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8043517)

  • 1. Transcriptional regulation of neu by RB and E1A in rat-1 cells.
    Yu D; Matin A; Hinds PW; Hung MC
    Cell Growth Differ; 1994 Apr; 5(4):431-8. PubMed ID: 8043517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The retinoblastoma gene product, Rb, represses neu expression through two regions within the neu regulatory sequence.
    Matin A; Hung MC
    Oncogene; 1994 May; 9(5):1333-9. PubMed ID: 7908732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.
    Yu D; Shi D; Scanlon M; Hung MC
    Cancer Res; 1993 Dec; 53(23):5784-90. PubMed ID: 7902209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of the neu promoter by the SV40 large T antigen.
    Matin A; Hung MC
    Cell Growth Differ; 1993 Dec; 4(12):1051-6. PubMed ID: 7906953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of adenovirus 5 E1A domains responsible for suppression of neu-mediated transformation via transcriptional repression of neu.
    Chen H; Yu D; Chinnadurai G; Karunagaran D; Hung MC
    Oncogene; 1997 Apr; 14(16):1965-71. PubMed ID: 9150363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
    Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
    Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC
    Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
    Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
    Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of apoptotic genes by Rb in human versus mouse cells.
    Young AP; Longmore GD
    Oncogene; 2004 Apr; 23(15):2587-99. PubMed ID: 15048095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.
    Ueno NT; Yu D; Hung MC
    Oncogene; 1997 Aug; 15(8):953-60. PubMed ID: 9285690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
    Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
    J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The retinoblastoma gene product suppresses neu oncogene-induced transformation via transcriptional repression of neu.
    Yu D; Matin A; Hung MC
    J Biol Chem; 1992 May; 267(15):10203-6. PubMed ID: 1350277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E1A oncogene of adenovirus-12 mediates trans-repression of MHC class I transcription in Ad5/Ad12 somatic hybrid transformed cells.
    Ge R; Liu X; Ricciardi RP
    Virology; 1994 Sep; 203(2):389-92. PubMed ID: 8053163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: repression of transcriptional activation by p53.
    Kannabiran C; Morris GF; Mathews MB
    Oncogene; 1999 Dec; 18(54):7825-33. PubMed ID: 10618724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
    Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
    Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with P105-Rb and the transformation of primary mouse cells.
    Rumpf H; Esche H; Kirch HC
    Virology; 1999 Apr; 257(1):45-53. PubMed ID: 10208919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal common domain of simian virus 40 large T and small t antigens acts as a transformation suppressor of the HER-2/neu oncogene.
    Lin YC; Peng JM; Wang WB
    Oncogene; 2000 May; 19(22):2704-13. PubMed ID: 10851070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL; Rand A; Kelm RJ; Getz MJ
    Oncogene; 2000 Jul; 19(30):3352-62. PubMed ID: 10918592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.